Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00694928 · ClinicalTrials.gov registry record · Phase 3
Vaginal Infection Study 2
A Phase 3 study, sponsored by Lumara Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 843
- Enrollment target
NCT00694928 is a Phase 3 study that has completed, run by Lumara Health. The registered enrollment target is 843 participants.
The verdict
NCT00694928, a Phase 3 study, has completed, sponsored by Lumara Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 843 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.
Interventions
- DRUG clindamycin phosphate/butoconazole nitrate
- DRUG butoconazole nitrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 843 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00694928
The ClinicalTrials.gov registry entry for NCT00694928 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 843 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumara Health, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which clindamycin phosphate/butoconazole nitrate is the first listed.
NCT00694928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00694928 about?
NCT00694928 is a clinical study titled "Vaginal Infection Study 2". This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.
What is the current status of trial NCT00694928?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 843 participants. The study started on 2008-05. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00694928?
The interventions under investigation include: clindamycin phosphate/butoconazole nitrate (DRUG), butoconazole nitrate (DRUG).
Who is sponsoring clinical trial NCT00694928?
This trial is sponsored by Lumara Health, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.